DG
Delek Group Portfolio holdings
AUM
$2.59B
Turnover
32.94%
1-Year Est. Return
1.24%
This Fund
S&P 500
This Quarter
Est. Return
-16.41%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.19B
AUM Growth
-$191M
(-8%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
6.58%
Top 10 Holdings %
Top 10 Hldgs %
23.34%
Holding
263
New
37
Increased
74
Reduced
71
Closed
47
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.6
years
Top 20 Avg Time Held Equity + Options
0.7
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$36.2M |
| 2 |
International Flavors & Fragrances
IFF
|
+$30.9M |
| 3 |
DuPont de Nemours
DD
|
+$25.5M |
| 4 |
JPMorgan Chase
JPM
|
+$23.5M |
| 5 |
Ovintiv
OVV
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ORBK
Orbotech Ltd
ORBK
|
+$46.5M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$30.8M |
| 3 |
AGN
Allergan plc
AGN
|
+$19.1M |
| 4 |
Virtu Financial
VIRT
|
+$17.3M |
| 5 |
Capri Holdings
CPRI
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.98% |
| 2 | Technology | 16.06% |
| 3 | Healthcare | 14.03% |
| 4 | Materials | 8.78% |
| 5 | Energy | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
DELISTED
Spirit Airlines, Inc.
SAVE
| – | – |
-64,500
| Closed | -$3.01M | – |
|
|
CLVS
252
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-42,000
| Closed | -$1.23M | – |
|
|
NBL
253
CALL
DELISTED
Noble Energy, Inc.
NBL
| – | – |
-535,000
| Closed | -$14M | – |
|
254
DELISTED
Arch Resources, Inc.
ARCH
| – | – |
-43,320
| Closed | -$3.85M | – |
|
|
AGN
255
DELISTED
Allergan plc
AGN
| – | – |
-100,746
| Closed | -$19.1M | – |
|
256
DELISTED
Anadarko Petroleum
APC
| – | – |
-9,000
| Closed | -$603K | – |
|
|
GZT
257
DELISTED
Gazit-globe Ltd
GZT
| – | – |
-144,062
| Closed | -$1.35M | – |
|
|
ORBK
258
DELISTED
Orbotech Ltd
ORBK
| – | – |
-787,471
| Closed | -$46.5M | – |
|
|
TSRO
259
DELISTED
TESARO, Inc.
TSRO
| – | – |
-30,000
| Closed | -$1.16M | – |
|
|
SODA
260
CALL
DELISTED
SodaStream International Ltd
SODA
| – | – |
-32,500
| Closed | -$4.65M | – |
|
|
AET
261
DELISTED
Aetna Inc
AET
| – | – |
-26,150
| Closed | -$5.27M | – |
|
Similar funds
KPAG
HIM
GAM
CAM
CI
LC
LIC
CB
Delek Group's Q4 2018 Portfolio in Review
As of Q4 2018, Delek Group held 263 positions worth $2.19B, down 8% from $2.38B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Delek Group deployed $144M of net new capital in Q4 2018, opening 37 new positions and adding to 74 existing holdings. Its largest new stake was DuPont de Nemours: 177,858 shares worth $24.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $30.8M trimmed.
- Delek Group's largest Q4 2018 buy was DuPont de Nemours: 177,858 shares worth $24.7M.
- Delek Group added most to Teva Pharmaceutical Industries Limited in Q4 2018, an estimated $36.2M increase.
- Delek Group's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $30.8M.
- Delek Group fully exited Orbotech Ltd in Q4 2018, selling an estimated $46.5M.
- Delek Group's ten largest holdings make up 23% of its $2.19B portfolio in Q4 2018.
- Delek Group opened 37 new positions and closed 47 in Q4 2018.
- Delek Group's portfolio value fell 8% quarter-over-quarter to $2.19B.
Based on Delek Group's 13F filing for Q4 2018, filed 14 Feb 2019.